FMP
Feb 20, 2023(Last modified: Dec 19, 2023)
Shockwave Medical (NASDAQ:SWAV) shares gained more than 4% on Friday after the company reported its Q4 results, with EPS coming in at $3.71, significantly better than the Street estimate of $1.00.
Revenue was $144 million, compared to the Street estimate of $142.66 million.
The company reiterated its full 2023-year outlook, expecting revenue to be in the range of $660-$680 million, assuming that global staffing issues continue to improve through the year. The Street estimate stands at $658.58 million. The company expects full-year OpEx to be the same percentage of revenue as in 2022 (approximately 61%).

In times of rising geopolitical tension or outright conflict, defense stocks often outperform the broader market as gove...

As Circle Internet (NYSE:CRCL) gains attention following its recent public listing, investors are increasingly scrutiniz...

LVMH Moët Hennessy Louis Vuitton (OTC:LVMUY) is a global leader in luxury goods, offering high-quality products across f...